A Specific Mechanism for Late Loss of Cardiac Allograft: The Antibody Mediated Rejection (AMR) as a Major Factor of Cardiac Allograft Vasculopathy (CAV)

被引：0
|
作者：
Toquet, C. [1 ]
Loupy, A. [2 ]
Rouvier, P. [3 ]
Varnous, S. [3 ]
Cazes, A. [2 ]
Tible, M. [2 ]
Beuscart, T. [2 ]
Jouven, X. [2 ]
Bruneval, P. [2 ]
Van Huyen, J. -P. Duong [2 ]
机构：
[1] CHU Nantes, F-44035 Nantes 01, France
[2] Univ Paris 05, Paris, France
[3] Hop La Pitie Salpetriere, Paris, France
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2013年 / 32卷 / 04期
关键词：
D O I：
10.1016/j.healun.2013.01.626
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
669
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [21] The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection
    Clerkin, Kevin J.
    Restaino, Susan W.
    Zorn, Emmanuel
    Vasilescu, Elena R.
    Marboe, Charles C.
    Mancini, Donna M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (09): : 1059 - 1066
  • [22] Antibody-Mediated Rejection Is Associated With Worse Survival But Not With Cardiac Allograft Vasculopathy (CAV) in a Large Cohort of 295 Heart Transplant Recipients
    Rodriguez, E.
    Askar, M.
    Tan, C. D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S105 - S106
  • [23] Donor-Transmitted Atherosclerosis and the Occurrence of Cardiac Antibody-Mediated Rejection Influenced on the Development of Cardiac Allograft Vasculopathy
    Watanabe, T.
    Yanase, M.
    Fujita, T.
    Fukushima, S.
    Nakajima, S.
    Kuroda, K.
    Iwasaki, K.
    Yajima, S.
    Tadokoro, N.
    Mochizuki, H.
    Anegawa, E.
    Sujino, Y.
    Yagi, N.
    Yoshitake, K.
    Kobayashi, J.
    Fukushima, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S249 - S249
  • [24] The effects of donor-specific antibody characteristics on cardiac allograft vasculopathy
    Wang, Maggie
    Patel, Nikhil J.
    Zhang, Xiaohai
    Kransdorf, Evan P.
    Azarbal, Babak
    Kittleson, Michelle M.
    Czer, Lawrence S. C.
    Kobashigawa, Jon A.
    Patel, Jignesh K.
    CLINICAL TRANSPLANTATION, 2021, 35 (12)
  • [25] The Effects of Donor-Specific Antibody Characteristics on Cardiac Allograft Vasculopathy
    Wang, M.
    Patel, N.
    Kransdorf, E.
    Azarbal, B.
    Zhang, X.
    Kobashigawa, J. A.
    Patel, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S41 - S41
  • [26] HLA Matching in Cardiac Transplantation - Impact on Cardiac Allograft Vasculopathy, Rejection and Donor Specific Antibodies
    Holzhauser, Luise
    Misra, Maneesh
    Miller, Tamari
    Kalantari, Sara
    Smith, Bryan
    Ann Nguyen
    Chung, Bow
    Sarswat, Nitasha
    Kim, Gene
    Marino, Susana
    Grinstein, Jonathan
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S157 - S157
  • [27] Association between acute rejection and cardiac allograft vasculopathy
    Dandel, M
    Hummel, M
    Wellnhofer, E
    Kapell, S
    Lehmkuhl, HB
    Hetzer, R
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (09): : 1064 - 1065
  • [28] Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation
    Bergmark, Brian A.
    Zelniker, Thomas A.
    Kim, Miae
    Mehra, Mandeep R.
    Stewart, Garrick C.
    Page, Deborah S.
    Woodcome, Erica L.
    Givertz, Michael M.
    CLINICAL TRANSPLANTATION, 2021, 35 (10)
  • [29] SPECIFIC INHIBITION OF CARDIAC ALLOGRAFT REJECTION
    JENKINS, AML
    SANDERS, JH
    WOODRUFF, MF
    BRITISH JOURNAL OF SURGERY, 1971, 58 (11) : 859 - &
  • [30] ACIDIC FIBROBLAST GROWTH-FACTOR (AFGF) AND UNTREATED MILD REJECTION ARE ASSOCIATED WITH THE DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV)
    ZHAO, XM
    CITRIN, BS
    FRIST, WH
    WILSON, JR
    FISCHELL, TA
    MILLER, GG
    YEOH, TK
    CIRCULATION, 1994, 90 (04) : 94 - 94
12345